KIP.MI 9.9 (+0%)
IT0005322950Drug ManufacturersDrug Manufacturers - Specialty & Generic

Kolinpharma (KIP.MI) Competitor Comparison

We are evaluating the key criteria listed to compare Kolinpharma (KIP.MI) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 3 years - KIP.MI ranking 5 / 54

These are the competitors of Kolinpharma in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 3 years
1. Zoetis ZTS
187.96
2. Phibro Animal Health PAHC
43.09
3. Evolus EOLS
19.51
4. Alvotech ALVO
15.66
5. Kolinpharma KIP.MI
11.59
6. Supernus Pharmaceuticals SUPN
11.14
7. Amphastar Pharmaceuticals AMPH
11.03
8. Perrigo PRGO
9.03
9. Alimera Sciences ALIM
8.97
10. Organogenesis Holdings ORGO
8.28
11. Vifor Pharma G2AB.F
6.24
12. Cronos Group CRON
5.13
13. Kamada KMDA
5.09
14. PetIQ PETQ
5.03
15. Solid Biosciences SLDB
4.67
16. Green Thumb Industries R9U2.F
4.39
17. Linc LNC
4.2
18. Taro Pharmaceutical Industries TARO
3.87
19. Avadel Pharmaceuticals AVDL
3.84
20. ProPhase Labs PRPH
3.8
21. Alpha Teknova TKNO
3.6
22. Elanco Animal Health ELAN
3.42
23. Embecta EMBC
3.39
24. Collegium Pharmaceutical COLL
3.2
25. Catalent CTLT
3.16
26. Zynerba Pharmaceuticals ZYNE
3
27. Pacira BioSciences PCRX
2.91
28. Curaleaf Holdings CURLF
2.56
29. Ironwood Pharmaceuticals IRWD
2.56
30. OptiNose OPTN
2.55
31. Bausch Health Companies BHC
2.45
32. Societal CDMO SCTL
2.41
33. Procaps Group PROC
2.14
34. Relmada Therapeutics RLMD
2.01
35. Theratechnologies THTX
1.95
36. Eagle Pharmaceuticals EGRX
1.94
37. Tilray Brands TLRY
1.91
38. Jupiter Wellness JUPW
1.84
39. SCYNEXIS SCYX
1.84
40. Emergent BioSolutions EBS
1.82
41. Ascend Wellness Holdings AAWH
1.76
42. Teva Pharmaceutical Industries TEVA
1.75
43. Flora Growth FLGC
1.74
44. Universe Pharmaceuticals UPC
1.74
45. Biofrontera BFRI
1.68
46. Neoleukin Therapeutics NLTX
1.57
47. Clever Leaves Holdings CLVR
1.47
48. Ayr Wellness 3KJB.F
1.41
49. Amneal Pharmaceuticals AMRX
1.31
50. ANI Pharmaceuticals ANIP
1.28
51. Journey Medical DERM
1.25
52. Cumberland Pharmaceuticals CPIX
1.17
53. Harrow Health HROW
1.1
54. Regencell Bioscience Holdings RGC
0.99

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.